RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 82 filers reported holding RECRO PHARMA INC in Q2 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,460,000 | -51.1% | 320,847 | -12.2% | 0.60% | -58.2% |
Q1 2020 | $2,985,000 | -81.1% | 365,352 | -57.5% | 1.43% | -69.8% |
Q4 2019 | $15,756,000 | +42.7% | 859,568 | -13.7% | 4.73% | +39.5% |
Q3 2019 | $11,039,000 | +46.1% | 996,281 | +34.1% | 3.39% | +53.4% |
Q2 2019 | $7,555,000 | – | 742,900 | – | 2.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |